tirzepatide injections for weight loss | GLP1 | Medical Tirzepatide is an advanced GLP-1

1 mg/mL concentration This is one of the lower concentrations available

"It was the most serious in a long history of serious adverse events associated with contaminated, super-potent, mislabeled, or otherwise poor quality compounded drugs," according to the FDA

[1] Allergic reactions range from local injection site reactions (erythema, swelling, pruritus) to serious systemic symptoms including generalized urticaria, angioedema affecting the face or throat, respiratory difficulty, and anaphylaxis with cardiovascular collapse

Patients with heart failure or advanced kidney disease may require specific fluid restrictions